$EXAS
EXACT SCIENCES CORP

2021 Q3 Form 10-Q Financial Statement

#000112414021000097 Filed on November 02, 2021

View on sec.gov

Income Statement

Concept 2021 Q3 2020 Q3 2020 Q2
Revenue $456.4M $408.4M $268.9M
YoY Change 11.76% 86.63% 34.52%
Cost Of Revenue $115.7M $95.06M $77.89M
YoY Change 21.75% 81.64% 52.31%
Gross Profit $319.4M $292.7M $170.4M
YoY Change 9.11% 76.3% 14.91%
Gross Profit Margin 69.99% 71.69% 63.38%
Selling, General & Admin $383.2M $252.1M $225.5M
YoY Change 52.0% 51.18% 48.47%
% of Gross Profit 119.95% 86.11% 132.35%
Research & Development $75.36M $31.47M $32.67M
YoY Change 139.45% -9.34% 9.01%
% of Gross Profit 23.59% 10.75% 19.17%
Depreciation & Amortization $22.30M $19.70M $17.60M
YoY Change 13.2% 134.52% 147.89%
% of Gross Profit 6.98% 6.73% 10.33%
Operating Expenses $481.5M $496.1M $237.4M
YoY Change -2.95% 145.86% 30.31%
Operating Profit -$162.0M -$203.3M -$67.01M
YoY Change -20.32% 469.15% 97.66%
Interest Expense -$8.773M $23.58M $22.91M
YoY Change -137.2% 78.53% 80.24%
% of Operating Profit
Other Income/Expense, Net -$8.773M -$1.955M -$1.388M
YoY Change 348.75% -52.5% -72.48%
Pretax Income -$170.8M -$205.3M -$68.40M
YoY Change -16.8% 415.26% 75.62%
Income Tax -$3.858M -$2.752M -$305.0K
% Of Pretax Income
Net Earnings -$166.9M -$202.5M -$68.09M
YoY Change -17.58% 399.79% 76.85%
Net Earnings / Revenue -36.58% -49.6% -25.33%
Basic Earnings Per Share -$0.97 -$1.35 -$0.45
Diluted Earnings Per Share -$0.97 -$1.35 -$0.45
COMMON SHARES
Basic Shares Outstanding 172.0M shares 150.2M shares 149.7M shares
Diluted Shares Outstanding 172.0M shares 150.2M shares 149.7M shares

Balance Sheet

Concept 2021 Q3 2020 Q3 2020 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.218B $1.283B $1.223B
YoY Change -5.03% 10.56% -1.35%
Cash & Equivalents $273.8M $806.7M $703.9M
Short-Term Investments $944.7M $476.3M $518.7M
Other Short-Term Assets $52.39M $36.60M $36.40M
YoY Change 43.13% 55.08% 53.59%
Inventory $95.17M $80.43M $82.22M
Prepaid Expenses
Receivables $249.6M $206.6M $163.6M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $1.616B $1.607B $1.505B
YoY Change 0.56% 21.72% 9.46%
LONG-TERM ASSETS
Property, Plant & Equipment $524.2M $456.5M $463.4M
YoY Change 14.84% 23.19% 38.13%
Goodwill $2.243B $1.238B $1.238B
YoY Change 81.19% 7062.87% 7062.87%
Intangibles $2.045B $871.7M $1.105B
YoY Change 134.61%
Long-Term Investments
YoY Change
Other Assets $59.24M $52.12M $23.90M
YoY Change 13.66% 113.84% -10.15%
Total Long-Term Assets $5.039B $2.748B $2.963B
YoY Change 83.38% 525.5% 627.72%
TOTAL ASSETS
Total Short-Term Assets $1.616B $1.607B $1.505B
Total Long-Term Assets $5.039B $2.748B $2.963B
Total Assets $6.654B $4.354B $4.468B
YoY Change 52.82% 147.51% 150.72%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $41.72M $26.06M $31.00M
YoY Change 60.07% 36.03% 55.8%
Accrued Expenses $304.7M $182.9M $139.5M
YoY Change 66.56% 35.68% -7.62%
Deferred Revenue $18.70M $22.40M $30.70M
YoY Change -16.52% 3100.0% 4285.71%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $320.3M $1.300M $1.300M
YoY Change 24540.23% -99.59% -99.58%
Total Short-Term Liabilities $710.2M $252.8M $222.3M
YoY Change 180.91% -47.4% -54.86%
LONG-TERM LIABILITIES
Long-Term Debt $1.900B $1.578B $1.557B
YoY Change 20.45% 215.02% 215.24%
Other Long-Term Liabilities $436.6M $62.82M $50.31M
YoY Change 594.96% 112.87% 68.13%
Total Long-Term Liabilities $436.6M $62.82M $50.31M
YoY Change 594.96% 112.87% 68.13%
TOTAL LIABILITIES
Total Short-Term Liabilities $710.2M $252.8M $222.3M
Total Long-Term Liabilities $436.6M $62.82M $50.31M
Total Liabilities $3.197B $2.017B $1.957B
YoY Change 58.47% 99.54% 92.5%
SHAREHOLDERS EQUITY
Retained Earnings -$2.421B -$1.531B -$1.312B
YoY Change 58.08% 27.87% 13.34%
Common Stock $5.878B $3.867B $3.821B
YoY Change 51.99% 98.71% 98.92%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $3.458B $1.731B $1.887B
YoY Change
Total Liabilities & Shareholders Equity $6.654B $4.354B $4.468B
YoY Change 52.82% 147.51% 150.72%

Cashflow Statement

Concept 2021 Q3 2020 Q3 2020 Q2
OPERATING ACTIVITIES
Net Income -$166.9M -$202.5M -$68.09M
YoY Change -17.58% 399.79% 76.85%
Depreciation, Depletion And Amortization $22.30M $19.70M $17.60M
YoY Change 13.2% 134.52% 147.89%
Cash From Operating Activities -$40.77M $81.80M -$6.900M
YoY Change -149.85% -381.1% -140.59%
INVESTING ACTIVITIES
Capital Expenditures -$38.87M -$14.00M -$21.00M
YoY Change 177.64% -72.92% -69.57%
Acquisitions
YoY Change
Other Investing Activities -$10.37M $30.90M $14.50M
YoY Change -133.57% -96.6% -143.28%
Cash From Investing Activities -$49.24M $16.80M -$6.400M
YoY Change -393.11% -98.04% -93.76%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 81.00K 4.200M 16.10M
YoY Change -98.07% 320.0% 192.73%
NET CHANGE
Cash From Operating Activities -40.77M 81.80M -6.900M
Cash From Investing Activities -49.24M 16.80M -6.400M
Cash From Financing Activities 81.00K 4.200M 16.10M
Net Change In Cash -89.94M 102.8M 2.800M
YoY Change -187.49% -87.6% -103.5%
FREE CASH FLOW
Cash From Operating Activities -$40.77M $81.80M -$6.900M
Capital Expenditures -$38.87M -$14.00M -$21.00M
Free Cash Flow -$1.904M $95.80M $14.10M
YoY Change -101.99% 323.89% -83.6%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q3 us-gaap Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List
FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001124140
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2021Q3 us-gaap Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List
FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2021-01-31#OtherAssetsNoncurrent
CY2021Q3 us-gaap Finance Lease Liability Current Statement Of Financial Position Extensible List
FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesCurrent
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2021-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-35092
dei Entity Registrant Name
EntityRegistrantName
EXACT SCIENCES CORPORATION
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
02-0478229
dei Entity Address Address Line1
EntityAddressAddressLine1
5505 Endeavor Lane
dei Entity Address City Or Town
EntityAddressCityOrTown
Madison
dei Entity Address State Or Province
EntityAddressStateOrProvince
WI
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
53719
dei City Area Code
CityAreaCode
608
dei Local Phone Number
LocalPhoneNumber
535-8815
dei Security12b Title
Security12bTitle
Common Stock, $0.01 par value per share
dei Trading Symbol
TradingSymbol
EXAS
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2021Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
172318821 shares
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
273779000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1491288000 USD
CY2021Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
944688000 USD
CY2020Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
348699000 USD
CY2021Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
249572000 USD
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
233185000 USD
CY2021Q3 us-gaap Inventory Net
InventoryNet
95167000 USD
CY2020Q4 us-gaap Inventory Net
InventoryNet
92265000 USD
CY2021Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
52385000 USD
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
33157000 USD
CY2021Q3 us-gaap Assets Current
AssetsCurrent
1615591000 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
2198594000 USD
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
524200000 USD
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
121075000 USD
CY2021Q3 us-gaap Liabilities
Liabilities
3196846000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
451986000 USD
CY2021Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
167911000 USD
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
125947000 USD
CY2021Q3 us-gaap Goodwill
Goodwill
2242535000 USD
CY2020Q4 us-gaap Goodwill
Goodwill
1237672000 USD
CY2021Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2044958000 USD
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
847123000 USD
CY2021Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
59241000 USD
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
63770000 USD
CY2021Q3 us-gaap Assets
Assets
6654436000 USD
CY2020Q4 us-gaap Assets
Assets
4925092000 USD
CY2021Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
41717000 USD
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
35709000 USD
CY2021Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
304714000 USD
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
233604000 USD
CY2021Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
19220000 USD
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
11483000 USD
CY2021Q3 us-gaap Short Term Bank Loans And Notes Payable
ShortTermBankLoansAndNotesPayable
1319000 USD
CY2020Q4 us-gaap Short Term Bank Loans And Notes Payable
ShortTermBankLoansAndNotesPayable
1319000 USD
CY2021Q3 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
313104000 USD
CY2020Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
312716000 USD
CY2021Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
30157000 USD
CY2020Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
38265000 USD
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
710231000 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
633096000 USD
CY2021Q3 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
1865647000 USD
CY2020Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
1861685000 USD
CY2021Q3 us-gaap Long Term Loans Payable
LongTermLoansPayable
21438000 USD
CY2020Q4 us-gaap Long Term Loans Payable
LongTermLoansPayable
22342000 USD
CY2021Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
436580000 USD
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
51342000 USD
CY2021Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
162950000 USD
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2020Q4 us-gaap Liabilities
Liabilities
2689540000 USD
CY2021Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2021Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000 shares
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000 shares
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
172242798 shares
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
172242798 shares
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
159423410 shares
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
159423410 shares
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
1723000 USD
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
1595000 USD
CY2021Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
5876644000 USD
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
4279327000 USD
CY2021Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
133000 USD
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
526000 USD
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2420910000 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2045896000 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
3457590000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
2235552000 USD
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6654436000 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4925092000 USD
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
456379000 USD
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
408363000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1293275000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1025052000 USD
CY2021Q3 us-gaap Cost Of Revenue
CostOfRevenue
115738000 USD
CY2020Q3 us-gaap Cost Of Revenue
CostOfRevenue
95061000 USD
us-gaap Cost Of Revenue
CostOfRevenue
339699000 USD
us-gaap Cost Of Revenue
CostOfRevenue
254559000 USD
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
75356000 USD
CY2020Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
31471000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
297158000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
107653000 USD
CY2021Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
196617000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
621897000 USD
CY2020Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
136481000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
577585000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
423092000 USD
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
186541000 USD
CY2020Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
115589000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
336265000 USD
CY2021Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
23940000 USD
CY2020Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
23430000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
70954000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
70199000 USD
CY2021Q3 us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
20210000 USD
CY2020Q3 us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
209666000 USD
us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
20210000 USD
CY2021Q3 us-gaap Costs And Expenses
CostsAndExpenses
618402000 USD
CY2020Q3 us-gaap Costs And Expenses
CostsAndExpenses
611698000 USD
us-gaap Costs And Expenses
CostsAndExpenses
1927503000 USD
us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
209666000 USD
us-gaap Costs And Expenses
CostsAndExpenses
1401434000 USD
CY2021Q3 us-gaap Other Operating Income
OtherOperatingIncome
0 USD
CY2020Q3 us-gaap Other Operating Income
OtherOperatingIncome
0 USD
us-gaap Other Operating Income
OtherOperatingIncome
0 USD
us-gaap Other Operating Income
OtherOperatingIncome
23665000 USD
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-162023000 USD
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-203335000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-634228000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-352717000 USD
CY2021Q3 exas Investment Income Expense Nonoperating
InvestmentIncomeExpenseNonoperating
-4093000 USD
CY2020Q3 exas Investment Income Expense Nonoperating
InvestmentIncomeExpenseNonoperating
2523000 USD
exas Investment Income Expense Nonoperating
InvestmentIncomeExpenseNonoperating
30524000 USD
CY2020Q3 exas Comprehensive Income Loss Before Tax
ComprehensiveIncomeLossBeforeTax
-202943000 USD
exas Investment Income Expense Nonoperating
InvestmentIncomeExpenseNonoperating
5532000 USD
CY2021Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-4680000 USD
CY2020Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-4478000 USD
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-13948000 USD
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-63382000 USD
CY2021Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-8773000 USD
CY2020Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1955000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
16576000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-57850000 USD
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-170796000 USD
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-205290000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-617652000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-410567000 USD
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3858000 USD
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2752000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-242638000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-5294000 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-166938000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-202538000 USD
us-gaap Net Income Loss
NetIncomeLoss
-375014000 USD
us-gaap Net Income Loss
NetIncomeLoss
-405273000 USD
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.97
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.97
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.35
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.35
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.19
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.19
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.71
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.71
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
171978000 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
171978000 shares
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
150155000 shares
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
150155000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
170978000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
170978000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
149346000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
149346000 shares
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-166938000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-202538000 USD
us-gaap Net Income Loss
NetIncomeLoss
-375014000 USD
us-gaap Net Income Loss
NetIncomeLoss
-405273000 USD
CY2021Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
66000 USD
CY2020Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
-405000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
-563000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
1159000 USD
CY2021Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax
0 USD
CY2020Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax
0 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax
0 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax
25000 USD
CY2021Q3 exas Comprehensive Income Loss Before Tax
ComprehensiveIncomeLossBeforeTax
-166872000 USD
exas Comprehensive Income Loss Before Tax
ComprehensiveIncomeLossBeforeTax
-375577000 USD
exas Comprehensive Income Loss Before Tax
ComprehensiveIncomeLossBeforeTax
-404089000 USD
CY2021Q3 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
0 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
0 USD
us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
-170000 USD
us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
0 USD
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-166872000 USD
CY2020Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-202943000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-375407000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-404089000 USD
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
2235552000 USD
CY2021Q1 us-gaap Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
344 shares
CY2021Q1 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
26000 USD
CY2021Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
8759000 USD
CY2021Q1 us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
22934000 USD
CY2021Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
158252000 USD
CY2021Q1 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
1254798000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-31164000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-162000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
3648995000 USD
CY2021Q2 us-gaap Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
197 shares
CY2021Q2 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
14000 USD
CY2021Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2858000 USD
CY2021Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
56285000 USD
CY2021Q2 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
16120000 USD
CY2021Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
12038000 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-176912000 USD
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-297000 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
3559101000 USD
CY2021Q3 us-gaap Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
39 shares
CY2021Q3 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
3000 USD
CY2021Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1755000 USD
CY2021Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
63603000 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-166938000 USD
CY2021Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
66000 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
3457590000 USD
CY2020Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
1957639000 USD
CY2020Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
4300000 USD
CY2020Q1 us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
12007000 USD
CY2020Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
29560000 USD
CY2020Q1 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
28597000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-134643000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-1617000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
1895843000 USD
CY2020Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
6638000 USD
CY2020Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
40039000 USD
CY2020Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
9799000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-68092000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
3206000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
1887433000 USD
CY2020Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
4470000 USD
CY2020Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
41476000 USD
CY2020Q3 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
250000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-202538000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-405000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
1730686000 USD
us-gaap Profit Loss
ProfitLoss
-375014000 USD
us-gaap Profit Loss
ProfitLoss
-405273000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
64267000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
53345000 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-928000 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-930000 USD
us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-1937000 USD
us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
1183000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-248716000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-6161000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
197180000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
111075000 USD
exas Post Combination Expense For Acceleration Of Unvested Equity
PostCombinationExpenseForAccelerationOfUnvestedEquity
80960000 USD
exas Post Combination Expense For Acceleration Of Unvested Equity
PostCombinationExpenseForAccelerationOfUnvestedEquity
0 USD
us-gaap Business Combination Step Acquisition Equity Interest In Acquiree Remeasurement Gain
BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain
30500000 USD
us-gaap Business Combination Step Acquisition Equity Interest In Acquiree Remeasurement Gain
BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain
0 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-50819000 USD
exas Amortization Deferred Amortization Of Deferred Financing Costs Debt Discounts Premiums And Issuance Costs Other Liabilities
AmortizationDeferredAmortizationOfDeferredFinancingCostsDebtDiscountsPremiumsAndIssuanceCostsOtherLiabilities
4948000 USD
exas Amortization Deferred Amortization Of Deferred Financing Costs Debt Discounts Premiums And Issuance Costs Other Liabilities
AmortizationDeferredAmortizationOfDeferredFinancingCostsDebtDiscountsPremiumsAndIssuanceCostsOtherLiabilities
340000 USD
exas Increase Decrease In Amortization Of Premium On Short Term Investments
IncreaseDecreaseInAmortizationOfPremiumOnShortTermInvestments
3265000 USD
exas Increase Decrease In Amortization Of Premium On Short Term Investments
IncreaseDecreaseInAmortizationOfPremiumOnShortTermInvestments
1040000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
70954000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
70199000 USD
us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
20210000 USD
us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
209666000 USD
us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
85337000 USD
us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
0 USD
exas Business Combination Contingent Consideration Gain Loss Change In Fair Value
BusinessCombinationContingentConsiderationGainLossChangeInFairValue
-10986000 USD
exas Business Combination Contingent Consideration Gain Loss Change In Fair Value
BusinessCombinationContingentConsiderationGainLossChangeInFairValue
0 USD
us-gaap Operating Lease Expense
OperatingLeaseExpense
18347000 USD
us-gaap Operating Lease Expense
OperatingLeaseExpense
11041000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
14038000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
73642000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1091000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
18472000 USD
exas Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-11834000 USD
exas Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-6135000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
64344000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-7608000 USD
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
20134000 USD
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-35097000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-77664000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
25078000 USD
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
1021557000 USD
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
890012000 USD
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
424830000 USD
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
559907000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
76374000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
48371000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
415549000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
6658000 USD
us-gaap Payments To Acquire Other Productive Assets
PaymentsToAcquireOtherProductiveAssets
58073000 USD
us-gaap Payments To Acquire Other Productive Assets
PaymentsToAcquireOtherProductiveAssets
0 USD
us-gaap Payments To Acquire Other Investments
PaymentsToAcquireOtherInvestments
13555000 USD
us-gaap Payments To Acquire Other Investments
PaymentsToAcquireOtherInvestments
10610000 USD
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
244000 USD
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-345000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1160522000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-395399000 USD
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0 USD
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
1125547000 USD
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
13372000 USD
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
15408000 USD
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
12038000 USD
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
9799000 USD
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
0 USD
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
150054000 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-4742000 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-938000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
20668000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
999762000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1217518000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
629441000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1491594000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
177528000 USD
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
274076000 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
806969000 USD
us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
21110000 USD
us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
7209000 USD
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
-563000 USD
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
1159000 USD
us-gaap Deferred Compensation Arrangement With Individual Shares Issued
DeferredCompensationArrangementWithIndividualSharesIssued
162606 shares
us-gaap Deferred Compensation Arrangement With Individual Shares Issued
DeferredCompensationArrangementWithIndividualSharesIssued
136559 shares
exas Issuance Of Stock To Fund Matching Contributions
IssuanceOfStockToFundMatchingContributions
22934000 USD
exas Issuance Of Stock To Fund Matching Contributions
IssuanceOfStockToFundMatchingContributions
12007000 USD
us-gaap Stock Issued During Period Shares Acquisitions
StockIssuedDuringPeriodSharesAcquisitions
9510436 shares
us-gaap Stock Issued During Period Shares Acquisitions
StockIssuedDuringPeriodSharesAcquisitions
382947 shares
us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
1270918000 USD
us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
28847000 USD
exas Business Combination Contingent Consideration Arrangements Increase Due To Acquisition
BusinessCombinationContingentConsiderationArrangementsIncreaseDueToAcquisition
350348000 USD
exas Business Combination Contingent Consideration Arrangements Increase Due To Acquisition
BusinessCombinationContingentConsiderationArrangementsIncreaseDueToAcquisition
0 USD
us-gaap Interest Paid Net
InterestPaidNet
10685000 USD
us-gaap Interest Paid Net
InterestPaidNet
9239000 USD
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Critical accounting policies are those that affect the Company’s financial statements materially and involve difficult, subjective or complex judgments by management, and actual results could differ from those estimates. These estimates include revenue recognition, valuation of intangible assets and goodwill, and accounting for income taxes among others. The Company’s critical accounting policies and estimates are explained further in the notes to the condensed consolidated financial statements in this Quarterly Report and the 2020 Form 10-K.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The spread of the coronavirus (“COVID-19”) has affected many segments of the global economy, including the cancer screening and diagnostics industry. The Company assessed certain accounting matters that generally require consideration of forecasted financial information in context with the information reasonably available to the Company and the unknown future impacts of COVID-19 as of September 30, 2021 and through the date of the filing of this Quarterly Report on Form 10-Q. The accounting matters assessed included, but were not limited to, the Company’s allowance for doubtful accounts and credit losses, equity investments, software, and the carrying value of the goodwill and other long-lived assets. The Company’s future assessment of the magnitude and duration of COVID-19, as well as other factors, could result in additional material impacts to the Company’s consolidated financial statements in future reporting periods.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The pandemic and related precautionary measures began to materially disrupt the Company's operations in March 2020 and may continue to disrupt the business for an unknown period of time. As a result, the pandemic impacted the Company's revenues and operating results for the three and nine months ended September 30, 2021. </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ultimate impact of COVID-19 depends on factors beyond the Company’s knowledge or control, including the duration and severity of the outbreak, as well as third-party actions taken to contain its spread and mitigate its public health effects. As a result, the Company is unable to estimate the extent to which COVID-19 will negatively impact its financial results or liquidity.</span></div>
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
ReclassificationsCertain prior year amounts have been reclassified to conform to the current year presentation in the condensed consolidated financial statements and accompanying notes to the condensed consolidated financial statements.
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
27903000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
27549000 shares
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
456379000 USD
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
408363000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1293275000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1025052000 USD
CY2021Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
18700000 USD
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
25000000 USD
CY2021Q3 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
200000 USD
CY2020Q3 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
5000 USD
CY2021Q3 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
200000 USD
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
24600000 USD
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
200000 USD
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
24600000 USD
CY2021Q3 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
274076000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
1491594000 USD
CY2021Q3 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
3068000 USD
CY2020Q4 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
1521000 USD
CY2021Q3 us-gaap Marketable Securities
MarketableSecurities
944688000 USD
CY2020Q4 us-gaap Marketable Securities
MarketableSecurities
348699000 USD
CY2021Q3 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
1218764000 USD
CY2020Q4 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
1840293000 USD
CY2021Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
941487000 USD
CY2021Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
279000 USD
CY2021Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
146000 USD
CY2021Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
941620000 USD
CY2020Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
936476000 USD
CY2020Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
696000 USD
CY2020Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
0 USD
CY2020Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
937172000 USD
CY2021Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
428534000 USD
CY2021Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
428711000 USD
CY2021Q3 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
512953000 USD
CY2021Q3 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
512909000 USD
CY2021Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
511190000 USD
CY2021Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
146000 USD
CY2021Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
0 USD
CY2021Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
0 USD
CY2021Q3 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
511190000 USD
CY2021Q3 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
146000 USD
CY2021Q3 us-gaap Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
4500000 USD
us-gaap Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
1900000 USD
CY2020Q3 us-gaap Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
33000 USD
us-gaap Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
-300000 USD
CY2021Q3 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
47971000 USD
CY2020Q4 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
43083000 USD
CY2021Q3 exas Inventory Finished And Semi Finished Goods
InventoryFinishedAndSemiFinishedGoods
47196000 USD
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
589524000 USD
CY2021Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
195287000 USD
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
137538000 USD
CY2020Q4 exas Inventory Finished And Semi Finished Goods
InventoryFinishedAndSemiFinishedGoods
49182000 USD
CY2021Q3 us-gaap Inventory Net
InventoryNet
95167000 USD
CY2020Q4 us-gaap Inventory Net
InventoryNet
92265000 USD
CY2021Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
719487000 USD
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
524200000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
451986000 USD
CY2021Q3 us-gaap Depreciation
Depreciation
22300000 USD
CY2020Q3 us-gaap Depreciation
Depreciation
19700000 USD
us-gaap Depreciation
Depreciation
64300000 USD
us-gaap Depreciation
Depreciation
53300000 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
969308000 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
174350000 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
794958000 USD
CY2021Q3 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
1250000000 USD
CY2021Q3 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
1250000000 USD
CY2021Q3 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
2219308000 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
174350000 USD
CY2021Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2044958000 USD
CY2020Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
958012000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
110889000 USD
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
847123000 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
23053000 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
92205000 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
92202000 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
91868000 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
90820000 USD
CY2021Q3 exas Finite Lived Intangible Asset Expected Amortization After Year Four
FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour
404810000 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
794958000 USD
CY2019Q4 us-gaap Goodwill
Goodwill
1203197000 USD
CY2020Q4 us-gaap Goodwill
Goodwill
1237672000 USD
CY2021Q3 us-gaap Goodwill
Goodwill
2242535000 USD
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
CY2020Q3 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
CY2021Q3 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
CY2021Q3 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
363600000 USD
us-gaap Regulatory Liability Amortization Period
RegulatoryLiabilityAmortizationPeriod
P2Y
CY2020Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
2500000 USD
CY2020Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
2477000 USD
exas Business Combination Contingent Consideration Arrangements Increase Due To Acquisition
BusinessCombinationContingentConsiderationArrangementsIncreaseDueToAcquisition
350348000 USD
exas Business Combination Contingent Consideration Gain Loss Change In Fair Value
BusinessCombinationContingentConsiderationGainLossChangeInFairValue
-10986000 USD
us-gaap Payment For Contingent Consideration Liability Investing Activities
PaymentForContingentConsiderationLiabilityInvestingActivities
164000 USD
CY2021Q3 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
363647000 USD
CY2019Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-187700000 USD
CY2020Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-50800000 USD
CY2021Q3 us-gaap Share Price
SharePrice
95.45
CY2021Q3 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1444000 USD
CY2020Q3 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1443000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
4284000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
3860000 USD
CY2021Q3 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
37000 USD
CY2020Q3 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
37000 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
110000 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
94000 USD
CY2021Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2020Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-50819000 USD
CY2021Q3 exas Coupon Interest Expense
CouponInterestExpense
2566000 USD
CY2020Q3 exas Coupon Interest Expense
CouponInterestExpense
2567000 USD
exas Coupon Interest Expense
CouponInterestExpense
7699000 USD
exas Coupon Interest Expense
CouponInterestExpense
7065000 USD
CY2021Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
4047000 USD
CY2020Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
4047000 USD
us-gaap Interest Expense Debt
InterestExpenseDebt
12093000 USD
us-gaap Interest Expense Debt
InterestExpenseDebt
61838000 USD
CY2021Q3 us-gaap Interest Expense Other
InterestExpenseOther
633000 USD
CY2020Q3 us-gaap Interest Expense Other
InterestExpenseOther
431000 USD
us-gaap Interest Expense Other
InterestExpenseOther
1855000 USD
us-gaap Interest Expense Other
InterestExpenseOther
1544000 USD
CY2021Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-4680000 USD
CY2020Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-4478000 USD
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-13948000 USD
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-63382000 USD
CY2020Q1 us-gaap Stock Issued During Period Shares Acquisitions
StockIssuedDuringPeriodSharesAcquisitions
400000 shares
us-gaap Oci Before Reclassifications Before Tax Attributable To Parent
OciBeforeReclassificationsBeforeTaxAttributableToParent
-292000 USD
us-gaap Reclassification From Aoci Current Period Before Tax Attributable To Parent
ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent
271000 USD
us-gaap Other Comprehensive Income Loss Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent
-563000 USD
us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
-170000 USD
us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
-170000 USD
us-gaap Oci Before Reclassifications Before Tax Attributable To Parent
OciBeforeReclassificationsBeforeTaxAttributableToParent
1159000 USD
us-gaap Reclassification From Aoci Current Period Before Tax Attributable To Parent
ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent
-25000 USD
us-gaap Other Comprehensive Income Loss Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent
1184000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
13400000 USD
CY2021Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
63600000 USD
CY2020Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
41500000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
283300000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
111100000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
15400000 USD
us-gaap Operating Lease Payments
OperatingLeasePayments
19835000 USD
us-gaap Operating Lease Payments
OperatingLeasePayments
12827000 USD
us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
723000 USD
us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
125000 USD
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
3805000 USD
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
620000 USD
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
60480000 USD
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
13662000 USD
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
4296000 USD
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
17420000 USD
CY2021Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P8Y1M20D
CY2020Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P8Y11M12D
CY2021Q3 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P3Y1M17D
CY2020Q3 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P3Y10M9D
CY2021Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0628
CY2020Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0683
CY2021Q3 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.0542
CY2020Q3 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.0587
CY2021Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
167900000 USD
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
125900000 USD
CY2021Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
182200000 USD
CY2021Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
19200000 USD
CY2021Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
163000000 USD
CY2020Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
132600000 USD
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
11500000 USD
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
121100000 USD
CY2021Q3 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
18700000 USD
CY2020Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
18600000 USD
CY2021Q3 us-gaap Finance Lease Liability
FinanceLeaseLiability
19100000 USD
CY2021Q3 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
5900000 USD
CY2021Q3 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
13200000 USD
CY2020Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
18700000 USD
CY2020Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
4700000 USD
CY2020Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
14000000 USD
exas Business Combination Provisional Information Initial Accounting Incomplete Adjustment Cash And Cash Equivalents
BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents
0 USD
exas Business Combination Provisional Information Initial Accounting Incomplete Adjustment Prepaid Expenses And Other Current Assets
BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPrepaidExpensesAndOtherCurrentAssets
0 USD
us-gaap Business Combination Provisional Information Initial Accounting Incomplete Adjustment Property Plant And Equipment
BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment
0 USD
exas Business Combination Provisional Information Initial Accounting Incomplete Adjustment Operating Lease Right Of Use Assets
BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets
0 USD
exas Business Combination Provisional Information Initial Accounting Incomplete Adjustment Other Long Term Assets
BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLongTermAssets
0 USD
us-gaap Business Combination Provisional Information Initial Accounting Incomplete Adjustment Intangibles
BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles
0 USD
exas Business Combination Provisional Information Initial Accounting Incomplete Adjustment Operating Assets
BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingAssets
0 USD
exas Business Combination Provisional Information Initial Accounting Incomplete Adjustment Accounts Payable
BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayable
0 USD
exas Business Combination Provisional Information Initial Accounting Incomplete Adjustment Accrued Liabilities
BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedLiabilities
-1862000 USD
exas Business Combination Provisional Information Initial Accounting Incomplete Adjustment Operating Lease Liabilities Current
BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseLiabilitiesCurrent
0 USD
exas Business Combination Provisional Information Initial Accounting Incomplete Adjustment Operating Lease Liabilities Noncurrent
BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseLiabilitiesNoncurrent
0 USD
exas Business Combination Provisional Information Initial Accounting Incomplete Adjustment Deferred Tax Liability
BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxLiability
0 USD
exas Business Combination Provisional Information Initial Accounting Incomplete Adjustment Operating Liabilities
BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLiabilities
-1862000 USD
exas Business Combination Provisional Information Initial Accounting Incomplete Adjustment Net Identifiable Assets Acquired
BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetIdentifiableAssetsAcquired
-1862000 USD
exas Business Combination Provisional Information Initial Accounting Incomplete Adjustment Goodwill
BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill
1862000 USD
exas Business Combination Provisional Information Initial Accounting Incomplete Adjustment Net Assets Acquired
BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssetsAcquired
0 USD
CY2020Q1 us-gaap Business Combination Consideration Transferred Including Equity Interest In Acquiree Held Prior To Combination1
BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1
8400000 USD
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
456379000 USD
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
408363000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1293275000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1025052000 USD
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3900000 USD
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2800000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-242600000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-5300000 USD
us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-239200000 USD
CY2021Q3 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
32700000 USD
CY2021Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
17700000 USD
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
16600000 USD

Files In Submission

Name View Source Status
0001124140-21-000097-index-headers.html Edgar Link pending
0001124140-21-000097-index.html Edgar Link pending
0001124140-21-000097.txt Edgar Link pending
0001124140-21-000097-xbrl.zip Edgar Link pending
exas-20210930.htm Edgar Link pending
exas-20210930.xsd Edgar Link pending
exas-20210930xexx311.htm Edgar Link pending
exas-20210930xexx312.htm Edgar Link pending
exas-20210930xexx321.htm Edgar Link pending
exas-20210930_cal.xml Edgar Link unprocessable
exas-20210930_def.xml Edgar Link unprocessable
exas-20210930_htm.xml Edgar Link completed
exas-20210930_lab.xml Edgar Link unprocessable
exas-20210930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending